<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04999618</url>
  </required_header>
  <id_info>
    <org_study_id>CVPMoscow</org_study_id>
    <nct_id>NCT04999618</nct_id>
  </id_info>
  <brief_title>A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology</brief_title>
  <acronym>DOUBLE-SKIN</acronym>
  <official_title>DOUBLE-SKIN: a New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology: a Randomised, Double-blind, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Center for Vascular Pathology, Moscow</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Center for Vascular Pathology, Moscow</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laser treatment (LT) is the first-line treatment for Vascular Pathology. However even when LT&#xD;
      is based on the selective photothermolysis it causes the first-degree burns. While being&#xD;
      typically benign by affecting only the epidermis, or outer layer of skin, the burn site is&#xD;
      remaining red, dry, and very painful. As Haemoblock contains nanoparticles of silver and is&#xD;
      known for both bactericidal and bacteriostatic effects, it likely decreases the potential for&#xD;
      infection postoperatively. Furthermore, after fibrin replaces the superficial structure&#xD;
      &quot;Hemoblock-albumin&quot;, the polyacrylate matrix is plasmolyzed which initiates the cascade of&#xD;
      signals required for the tissue regeneration processes. Objective of the study was to examine&#xD;
      the effect of the Regenerative Solution &quot;Hemoblock&quot; in lowering postoperative complications&#xD;
      in children diagnosed with Vascular Pathology undergoing a laser surgery if delivered with&#xD;
      transdermal patches.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Actual">October 27, 2021</completion_date>
  <primary_completion_date type="Actual">August 27, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Participants, clinicians and the research team, completing baseline and follow-up assessments were masked to group allocation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Preventing negative outcomes of postoperative infection</measure>
    <time_frame>Early postoperative period and at 3 weeks</time_frame>
    <description>Validated scales</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Preventing prolonged functional recovery</measure>
    <time_frame>Early postoperative period and at 3 weeks</time_frame>
    <description>Validated scales</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Preventing likelihood of mental health issues</measure>
    <time_frame>Early postoperative period and at 3 weeks</time_frame>
    <description>Validated scales</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Vascular Diseases</condition>
  <condition>Vascular Malformation</condition>
  <condition>Capillary Malformation-Arteriovenous Malformation</condition>
  <condition>Port-Wine Stain</condition>
  <condition>Sturge-Weber Syndrome</condition>
  <condition>Vascular Tumor</condition>
  <arm_group>
    <arm_group_label>Group with Haemoblock (A)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group without Haemoblock (B)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Haemoblock</intervention_name>
    <description>Delivering with transdermal patches</description>
    <arm_group_label>Group with Haemoblock (A)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Delivering with transdermal patches</description>
    <arm_group_label>Group without Haemoblock (B)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  clinically diagnosed Vascular Pathology&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age&#xD;
&#xD;
          -  severe allergic reaction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ekaterina M Listovskaya, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Vascular Anomalies Center (VAC) &quot;Hemangioma&quot;,</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dmitry V Romanov, MD</last_name>
    <role>Study Chair</role>
    <affiliation>The Vascular Anomalies Center (VAC) &quot;Hemangioma&quot;</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander Plotkin, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Moscow Regional Research Institute of Blood</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Vascular Anomalies Center (VAC) &quot;Hemangioma&quot;</name>
      <address>
        <city>Moscow</city>
        <zip>109028</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 17, 2021</study_first_submitted>
  <study_first_submitted_qc>August 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 11, 2021</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vascular Diseases</keyword>
  <keyword>Laser treatment</keyword>
  <keyword>Capillary Malformation</keyword>
  <keyword>Port-Wine Stain</keyword>
  <keyword>Vascular Tumor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemangioma, Capillary</mesh_term>
    <mesh_term>Sturge-Weber Syndrome</mesh_term>
    <mesh_term>Neoplasms, Vascular Tissue</mesh_term>
    <mesh_term>Vascular Neoplasms</mesh_term>
    <mesh_term>Brain Stem Infarctions</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Arteriovenous Malformations</mesh_term>
    <mesh_term>Vascular Malformations</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Port-Wine Stain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

